The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

NCT06656962 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)

Interventions

DRUG: Telitacicept 160mg
DRUG: Prednisone (and methylprednisolone)
DRUG: Cyclophosphamide

Sponsor

Renmin Hospital of Wuhan University